LifeStance Health Group, Inc.

NASDAQ:LFST

Medical - Care Facilities

Healthcare
$13.77 +1.99%

+$0.17 today

Market cap
$5.24B
Beta
1.19
P/E (TTM)
146.6
EPS (TTM)
$0.06
52W Low $3.74High $8.89

Volume 6.60M

Average 3.91M

LFST EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

LifeStance Health Group, Inc.NASDAQ: LFST

EBITDA · Q2 FY2026 · quarter ended Jun 2026

EBITDA growth accelerates

Q2 FY2026 EBITDA of $44.34M rose 304.4% year over year, ahead of the +132.4% change in trailing-twelve-month EBITDA. Sequentially, it rose 27.1% from the prior quarter.

Context

  • EBITDA amounted to 5.5% of revenue in FY2025, up 2.3 pp from a year earlier.
  • EBITDA increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 8 analysts of $173.8M (+120.6%) for the fiscal year ending Dec 2026, a step up from the +97.6% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$44.34M+27.1% QoQ
Last fiscal yearDec 2025
$78.78M+97.6% YoY
LTMJun 2026
$131.66M+132.4% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+304.4%+59.3%-245.1 pp
1 year+97.6%+120.6%+23.0 pp
3-year CAGR—+57.2%—
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
78.78M USD
Year-over-year change
+97.6%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How LFST compares with its peers on the latest reported figures

  • LFST's LTM Jun 2026 EBITDA of $131.66M is the 3rd highest of the 7 companies compared; the peer median is $31.97M.
  • Its year-over-year change of +132.4% is the highest of 7, against a peer median of -92.5%.
  • EBITDA amounts to 8.3% of revenue for LFST, versus a peer median of 5.3%.
LFST Competitors Peer median
EBITDA for LFST and competitors
Company Period LTM YoY 3-year CAGR% of revenue
UHSUniversal Health Services, Inc.LTM Jun 2026$2.82B +16.2%+20.3%15.6%
BTSGBrightSpring Health Services, Inc. Common StockLTM Sep 2026$709.15M +59.1%+5.5%4.6%
LFSTLifeStance Health Group, Inc.LTM Jun 2026$131.66M +132.4%—8.3%
PRVAPrivia Health Group, Inc.LTM Jun 2026$68.17M +79.4%—2.9%
LFMDLifeMD, Inc.LTM Mar 2026-$4.22M -227.5%—1.9%
HIMSHims & Hers Health, Inc.LTM Sep 2026-$172.46M -201.2%—6.0%
ACHCAcadia Healthcare Company, Inc.LTM Sep 2026-$664.91M -246.0%—19.5%
Peer median (excluding LFST) $31.97M-92.5%+12.9%5.3%

Competitors are the stored peer set for LFST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue667.51M859.54M1.06B1.25B1.42B
Cost of Revenue466M622.53M753.57M848.57M963.19M
Gross Profit201.51M237.02M302.1M402.4M461.1M
Gross Margin30.2%27.6%28.6%32.2%32.4%
Research & Development00000
Selling, General & Admin433.73M377.99M410.79M363.06M382.2M
Operating Expenses487.86M447.19M491.23M434.01M436.95M
Depreciation & Amortization54.14M69.2M80.44M70.95M54.75M
EBITDA(240.06M)(143.6M)(104.93M)39.87M78.78M
EBITDA Margin-36.0%-16.7%-9.9%3.2%5.5%
Operating Income(286.35M)(210.17M)(189.13M)(31.61M)24.15M
Operating Margin-42.9%-24.5%-17.9%-2.5%1.7%
Interest Income00000
Interest Expense38.91M19.93M21.22M26.54M11.66M
Other Income / Expenses(46.75M)(22.56M)(17.45M)(26M)(11.79M)
Income Before Tax(333.11M)(232.73M)(206.58M)(57.61M)12.36M
Pre-Tax Margin-49.9%-27.1%-19.6%-4.6%0.9%
Income Tax Expense(25.91M)(17.17M)(20.32M)(170K)2.7M
Net Income(307.2M)(215.56M)(186.26M)(57.44M)9.66M
Net Margin-46.0%-25.1%-17.6%-4.6%0.7%
EPS (Basic)(1.05)(0.61)(0.51)(0.15)0.03
EPS (Diluted)(1.05)(0.61)(0.51)(0.15)0.02
Weighted Avg Shares327.52M355.28M367.46M379.15M386.02M
Weighted Avg Shares (Diluted)327.52M355.28M367.46M379.15M391.14M

LifeStance Health Group, Inc.

NASDAQ:LFST

Intrinsic Alpha fair value

Locked

Current Price

$13.77

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.